Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis

Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis

Background: Eosinophilic otitis media (EOM) is a refractory condition associated with eosinophilic chronic rhinosinusitis and bronchial asthma. EOM is characterized by type-2 inflammation and is refractory to various treatments. We investigated the efficacy of dupilumab, interleukin-4 receptor alpha...

Full description

Bibliographic Details
Main Authors: Daiki Nakashima, Tsuguhisa Nakayama, Syunsuke Minagawa, Tetsuya Adachi, Chieko Mitsuyama, Yoko Shida, Tsuneya Nakajima, Shin-ichi Haruna, Yoshinori Matsuwaki
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Allergology International
Subjects:
Eosinophilic otitis media
Eosinophilic chronic rhinosinusitis
Bronchial asthma
Dupilumab
Corticosteroid
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893023000382

Internet

http://www.sciencedirect.com/science/article/pii/S1323893023000382

Similar Items